RAPP - Rapport Therapeutics Inc.
IEX Last Trade
21.86
2.060 9.424%
Share volume: 108,481
Last Updated: Fri 30 Aug 2024 09:59:01 PM CEST
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) :
0.87%
PREVIOUS CLOSE
CHG
CHG%
$19.80
2.06
10.40%
Fundamental analysis
4%
Profitability
0%
Dept financing
0%
Liquidity
0%
Performance
10%
Performance
5 Days
-2.47%
1 Month
3.67%
3 Months
4.57%
6 Months
4.57%
1 Year
4.57%
2 Year
4.57%
Key data
Stock price
$21.86
DAY RANGE
N/A - N/A
52 WEEK RANGE
$16.55 - $28.08
52 WEEK CHANGE
$0.05
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
11/07/2024
Company detail
CEO:
Region: US
Website:
Employees: 0
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Sector: Professional, Scientific, and Technical Services
Region: US
Website:
Employees: 0
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Sector: Professional, Scientific, and Technical Services
Recent news